Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to TALK:PC53 20 |u:www.enterprize.cam.ac.uk.  Search for TALK:PC53 20 |u:www.enterprise.cam.ac.uk instead.
1 - 10 of 21 search results for TALK:PC53 20 |u:www.enterprise.cam.ac.uk or TALK:PC53 20 |u:www.enterprize.cam.ac.uk where 0 match all words and 21 match some words.
  1. Results that match 1 of 2 words

  2. Latest news, case studies and blogs – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/latest-news/
    Thumbnail for Latest news, case studies and blogs – Cambridge Enterprise 11 Apr 2024: Catch up on our latest developments to see how we're creating impact for the benefit of society, the economy and the University.
  3. Thumbnail for Cambridge Enterprise – knowledge transfer & research impact 13 Jun 2024: Cambridge Enterprise supports University of Cambridge members in achieving knowledge transfer and research impact for the benefit of society.
  4. Genius of the place: Cambridge’s Creative Promise – Cambridge…

    https://www.enterprise.cam.ac.uk/genius-of-the-place-cambridges-creative-promise/
    Thumbnail for Genius of the place: Cambridge’s Creative Promise – Cambridge Enterprise 20 Jun 2024: 20 June 2024. Genius of the place: Cambridge’s Creative Promise. Share:.
  5. New fast track equity model – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/new-fast-track-equity-model/
    Thumbnail for New fast track equity model – Cambridge Enterprise 24 Jun 2024: 20% equity for patented Therapeutic Technologies. Under the University IP Policy, University of Cambridge founders do not require a licence to non-patented Other Technologies in certain situations. ... The fast-track model has four streams, ranging from
  6. Fast track equity option – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/fast-track-equity-option/
    Thumbnail for Fast track equity option – Cambridge Enterprise 24 Jun 2024: 20% equity for patented Therapeutic Technologies. Under the University IP Policy, University of Cambridge founders do not require a licence to non-patented Other Technologies in certain situations. ... The fast-track model has four streams, ranging from
  7. Cambridge Enterprise Ventures – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-external-organisations/cambridge-enterprise-ventures/
    Thumbnail for Cambridge Enterprise Ventures – Cambridge Enterprise 25 Jun 2024: Over 20 years of investing at the University of Cambridge has seen a host of successes including XO1, BlueGnome, Cambridge CMOS Sensors, Centessa, Gyroscope, Solexa, Quethera and VocalIQ.
  8. Harnessing the power of innovation – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/harnessing-the-power-of-innovation/
    Thumbnail for Harnessing the power of innovation – Cambridge Enterprise 6 Jun 2024: The change that has taken place over the last 20 or 30 years is extraordinary – and welcome. ... What one piece of advice would you give your 20-year old self given what you’ve learnt in your life or career?
  9. Frequently Asked Questions (FAQs) - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/contact/faqs/
    26 Mar 2024: Once granted, the term of a patent, or the time it is enforceable, is of 20 years from the initial filing.
  10. MAT2A inhibitors to treat BK polyomavirus disease – Cambridge…

    https://www.enterprise.cam.ac.uk/opportunities/mat2a-inhibitors-to-treat-bk-polyomavirus-disease/
    Thumbnail for MAT2A inhibitors to treat BK polyomavirus disease – Cambridge Enterprise 19 Apr 2024: Technology is the first specific treatment for BKPyV-associated diseases (e.g. PVAN and HC) in immunosuppressed patients, holding the potential to benefit around 20,000 affected transplant recipients annually.
  11. Unleashing Cambridge’s start-up potential requires a better deal for…

    https://www.enterprise.cam.ac.uk/unleashing-cambridges-start-up-potential-requires-a-better-deal-for-founders/
    Thumbnail for Unleashing Cambridge’s start-up potential requires a better deal for founders – Cambridge Enterprise 15 May 2024: It will range from 5% to 20% of equity, fully dilutable, depending on the technology from software to therapeutics. ... This along with a range of other measures is intended to increase our spin-out creation to 20 companies a year.

Refine your results

Format

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Your search history is empty.